MIG
JAZZ icon

Mariner Investment Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Mariner Investment Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-10,000
Closed -$4K – 220
2015
Q3 		$4K Buy
+10,000
New +$1.72M ﹤0.01% 186
2015
Q2 		– Sell
-21,000
Closed -$31K – 226
2015
Q1 		$31K Buy
+21,000
New +$3.6M 0.01% 156

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Mariner Investment Group's JAZZ Position: Q3 2016 in Review

Mariner Investment Group sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2016, closing a stake of 28,400 shares — an estimated $4.01M sold.

Mariner Investment Group first reported a position in JAZZ in Q1 2014 and held it in 10 quarters. The position peaked at $6.33M in Q4 2015. 326 funds tracked by Wall St. Rank hold JAZZ as of Q3 2016.

  • Mariner Investment Group reported no remaining Jazz Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Mariner Investment Group sold 28,400 Jazz Pharmaceuticals shares in Q3 2016, an estimated $4.01M.
  • Mariner Investment Group first reported a position in Jazz Pharmaceuticals in Q1 2014 and held it in 10 quarters.
  • Mariner Investment Group's Jazz Pharmaceuticals position peaked at $6.33M in Q4 2015.
  • 326 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2016.

Based on Mariner Investment Group's 13F filing for Q3 2016, filed 3 Nov 2016.